Damon Runyon Cancer Resources

July 20, 2006

Joseph A. Califano, III, MD (Damon Runyon-Lilly Clinical Investigator '01-'06) and colleagues uncovered a new pathway in the etiology of thyroid cancer. They report that the silencing of cellular brakes or tumor suppressor genes by a process called methylation may be an important step in the progression of this devastating cancer.